REG - Quantum Helium Ltd - Director/PDMR Shareholding

Quantum HeliumAnnouncement

08/01/2026 07:05

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260108:nRSH1474Oa&default-theme=true

RNS Number : 1474O  Quantum Helium Limited  08 January 2026

 

8 January 2026

 

Quantum Helium Limited

("Quantum" or the "Company")

 

 

Director / PDMR Shareholding

Quantum Helium Limited (AIM: QHE) announces that Non-Executive Director,
Graham Duncan, has informed the Company that between 29 December 2025 and 7
January 2026, he purchased a total of 39,300,000 Ordinary Shares in the
Company at a price of 0.039 pence per share.

Following these trades, Graham Duncan now has a beneficial interest in
100,250,617 Ordinary Shares, representing 0.30% of the current total voting
rights of the Company.

 

Market Abuse Regulation (MAR) Disclosure

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulations
(EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the
European Union (Withdrawal) Act 2018. Upon the publication of this
announcement via Regulatory Information Service ('RIS'), this information is
now considered to be in the public domain.

 

 

Enquiries:

 Quantum Helium Limited     NOMAD and Joint Broker

 Carl Dumbrell              SP Angel Corporate Finance LLP

 Chairman                   Stuart Gledhill / Richard Hail / Adam Cowl

                            +44 (0) 20 3470 0470
 Brand Communications       Joint Broker

 Alan Green                 CMC Markets UK Plc

 Tel: +44 (0) 7976 431608   Douglas Crippen

                            +44 (0) 020 3003 8632

 

Updates on the Company's activities are regularly posted on its website:
www.quantum-helium.com

 

Notes to editors

Quantum (AIM: QHE) is a helium, hydrogen and hydrocarbon exploration,
development, and production company with projects in the US and Australia.
Quantum's strategic objectives remain consistent: to identify opportunities
which will provide operating cash flow and have development upside, in
conjunction with progressing exploration. The Company has several projects in
the US, in addition to royalty interests in Australia.

 

 

 

 1.  Details of PDMR/person closely associated with them ("PCA")
 a)  Name                                                         Graham Duncan

 2.  Reason for the notification
 a)  Position/status                                              Non-Executive Director

 b)  Initial notification/                                        Initial notification

amendment
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Full name of the entity                                      Quantum Helium Limited
 b)  Legal Entity Identifier code                                 213800PWZID9URNNGZ54
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of Quantum Helium Ltd

Identification code

AU0000XINET1
 b)  Nature of the transaction                                    Purchase of Ordinary Shares

 c)  Price(s) and volume(s)                                       Price(s)  Volume(s)
                                                                  0.039p    39,300,000

 d)  Aggregated information

     -     Aggregated volume                                      39,300,000

     -     Price

                                                                  0.039p
 e)  Date of the transaction                                      1)  29 December 2025 to 7 January 2026

 f)  Place of the transaction                                     London Stock Exchange

d)

Aggregated information

-     Aggregated volume

-     Price

 

39,300,000

 

0.039p

e)

Date of the transaction

1)  29 December 2025 to 7 January 2026

 

 

 

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFIFSRLDITIIR



            Copyright 2019 Regulatory News Service, all rights reserved